RETRACTED: Cigarette Smoke-induced Oxidative/Nitrosative Stress Impairs VEGF- and Fluid Shear Stress-Media Signaling in Endothelial Cells (Retracted article. See vol. 18, pg. 1535, 2013)

被引:33
作者
Edirisinghe, Indika [1 ]
Arunachalam, Gnanapragasam [1 ]
Wong, Chelsea [2 ,3 ]
Yao, Hongwei [1 ]
Rahman, Arshad [1 ,4 ]
Phipps, Richard P. [1 ]
Jin, Zheng-Gen [2 ,3 ]
Rahman, Irfan [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA
[4] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA
关键词
NITRIC-OXIDE SYNTHASE; PROINFLAMMATORY CYTOKINE RELEASE; NF-KAPPA-B; OXIDATIVE STRESS; GROWTH-FACTOR; PULMONARY-HYPERTENSION; INDUCED EMPHYSEMA; TOBACCO-SMOKE; ACTIVATION; DYSFUNCTION;
D O I
10.1089/ars.2009.2874
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
VEGF receptor 2 (VEGFR2), a tyrosine kinase receptor, is activated by VEGF and fluid shear stress (FSS), and its downstream signaling is important in the regulation of endothelial functions, such as cell migration, endothelium-dependent relaxation, and angiogenesis. Cigarette smoke (CS) is known to cause oxidative/nitrosative stress, leading to modifications of tyrosine kinase receptors and impaired downstream signaling. We hypothesized that CS-induced oxidative/nitrosative stress impairs VEGF-and FSS-mediated VEGFR2 activation, leading to endothelial dysfunction. Human lung microvascular endothelial cells and human umbilical vein endothelial cells were treated with different concentrations of cigarette smoke extract (CSE) to investigate the VEGF-or FSS-mediated VEGFR2 phosphorylation and its downstream signaling involved in endothelial function. CSE treatment impaired both VEGF-and FSS-mediated VEGFR2 phosphorylation, resulting in impaired endothelial nitric oxide synthase (eNOS) phosphorylation by Akt. CS-derived reactive oxygen/nitrogen species react with VEGFR2, rendering VEGFR2 inactive for its downstream signaling. Pretreatment with nitric oxide scavenger (PTIO), reactive oxygen species scavengers (combination of SOD with catalase), and N-acetyl-l-cysteine, significantly attenuated the CSE-induced impairment of VEGF-mediated Akt and eNOS phosphorylation. These findings suggest that CSE-induced oxidative/nitrosative stress impairs VEGF-and FSS-mediated endothelial cell function and has important implications in the pathogenesis of CS-induced pulmonary and cardiovascular diseases associated with endothelial dysfunction. Antioxid. Redox Signal. 12, 1355-1369.
引用
收藏
页码:1355 / 1369
页数:15
相关论文
共 63 条
[1]   The pathophysiology of cigarette C-V smoking and cardiovascular disease - An update [J].
Ambrose, JA ;
Barua, RS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) :1731-1737
[2]   Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment [J].
Bagi, Z ;
Cseko, C ;
Tóth, E ;
Koller, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (06) :H2277-H2283
[3]   Pulmonary hypertension in chronic obstructive pulmonary disease [J].
Barberà, JA ;
Peinado, VI ;
Santos, S .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (05) :892-905
[4]   Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells [J].
Berk, Bradford C. .
CIRCULATION, 2008, 117 (08) :1082-1089
[5]   Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases [J].
Boo, YC ;
Jo, H .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (03) :C499-C508
[6]   Shear stress stimulates phosphorylation of eNOS at Ser635 by a protein kinase A-dependent mechanism [J].
Boo, YC ;
Hwang, J ;
Sykes, M ;
Michell, BJ ;
Kemp, BE ;
Lum, H ;
Jo, H .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (05) :H1819-H1828
[7]   Understanding eNOS for pharmacological modulation of endothelial function: A translational view [J].
Braam, Branko ;
Verhaar, Marianne C. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (17) :1727-1740
[8]  
CARP H, 1978, AM REV RESPIR DIS, V118, P617
[9]   Endothelial dysfunction: Does it matter? Is it reversible? [J].
Celermajer, DS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :325-333
[10]  
Chavakis E, 2001, CIRCULATION, V103, P2102